---
figid: PMC3024542__ukmss-31731-f0002
figtitle: Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug
  Design
organisms:
- Escherichia coli
- Escherichia coli IS1
- Escherichia coli 27A
- Bos taurus
- Diaporthe sclerotioides
- Equus caballus
- Phaeoacremonium amygdalinum
- Homo sapiens
- Calloplesiops altivelis
organisms_ner:
- Drosophila melanogaster
pmcid: PMC3024542
filename: ukmss-31731-f0002.jpg
figlink: /pmc/articles/PMC3024542/figure/F2/
number: F2
caption: Ligand substitution as a prodrug strategy for metallochemotherapeutics; a)
  general scheme of prodrug activation by ligand substitution; hydrolysis of a metal-halide
  bond is a typical activation pathway of metal-based anticancer drugs, as exemplified
  by the activation of cisplatin (b) and a ruthenium-arene complex (c).
papertitle: Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug
  Design.
reftext: Pieter C. A. Bruijnincx, et al. Adv Inorg Chem. ;61:1-62.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8368211
figid_alias: PMC3024542__F2
figtype: Figure
redirect_from: /figures/PMC3024542__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3024542__ukmss-31731-f0002.html
  '@type': Dataset
  description: Ligand substitution as a prodrug strategy for metallochemotherapeutics;
    a) general scheme of prodrug activation by ligand substitution; hydrolysis of
    a metal-halide bond is a typical activation pathway of metal-based anticancer
    drugs, as exemplified by the activation of cisplatin (b) and a ruthenium-arene
    complex (c).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - be
  - mn
  - Pdfr
  - Gr5a
  - ci
  - ru
  - cisplatin
---
